ondansetron has been researched along with Duodenal Ulcer in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Duodenal Ulcer: A PEPTIC ULCER located in the DUODENUM.
Excerpt | Relevance | Reference |
---|---|---|
"The effect of central administration of ondansetron, a 5-hydroxytryptamine-3 (5-HT3) receptor antagonist on gastric secretion and gastric cytoprotection was evaluated using four different models of gastric ulcers and cysteamine induced duodenal ulcer." | 7.75 | Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers. ( Asad, M; Dhamanigi, SS; Prasad, VS; Ramesh, ST, 2009) |
"The effect of central administration of ondansetron, a 5-hydroxytryptamine-3 (5-HT3) receptor antagonist on gastric secretion and gastric cytoprotection was evaluated using four different models of gastric ulcers and cysteamine induced duodenal ulcer." | 3.75 | Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers. ( Asad, M; Dhamanigi, SS; Prasad, VS; Ramesh, ST, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ramesh, ST | 1 |
Asad, M | 1 |
Dhamanigi, SS | 1 |
Prasad, VS | 1 |
1 other study available for ondansetron and Duodenal Ulcer
Article | Year |
---|---|
Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers.
Topics: Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Duodenal Ulcer; Gastric Ac | 2009 |